| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2412fc074b512aabbaaa3fe5cb383a01 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate |
2000-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11146815da8dfd6bdb4fcaaf72a89712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4af4346d4007207d6f2b5188ceecb183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a253a702a77211591c7d0dd1a2bb067a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eedf91f733e1493ba8faa2513815df4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93481201a32f8f6817eae97b7a894ba0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e217b5ea3d7ca0fd245b8d4328a1a2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e2996b3fdf6f67b49817426db24b775 |
| publicationDate |
2002-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-10061525-A1 |
| titleOfInvention |
Lipophilic oligopeptides as carriers for pharmaceuticals |
| abstract |
The invention relates to the production and use of lipophilic oligopeptides as carrier substances which enable pharmaceuticals to be transported into the CNS and to have a selective action on cells and receptors. DOLLAR A This goal is achieved in that pharmaceuticals are linked with lipophilic oligopeptides of the general formula I in an ester- or amide-like manner. Due to the high content of carrier I in alpha-aminoisobutyric acid (Aib) and its lipophilic properties, the pharmaceuticals associated with the carrier become CNS-common. Neutrotransmitters, drugs against neurodegenerative diseases, antibiotics can be used as pharmaceuticals. Antiparasitic and cytostatic agents are used. |
| priorityDate |
2000-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |